GSTs as a therapeutic target GSTs have emerged as a promising therapeutic target because specific isozymes are overexpressed in a wide variety of tumors and may play a role in the etiology of other diseases, including neurodegenerative diseases, multiple sclerosis, and asthma (Tew, 1994
doi: 10.1097/00007611-195208000-00029 178
Q2: How long from development to delivery
A substantial body of clinical evidence accumulated over the past two decades, consistently demonstrates that NSW is able to significantly suppress endogenous melatonin secretion, as measured through urinary and salivary metabolites, primarily aMT6s and 6-hydroxymelatonin sulfate (6-OHMS) 171
Every NOVA Labs peptide is third-party HPLC and mass-spec tested to 99% purity, with a Certificate of Analysis on every peptide cold-chain delivered across Dubai, Abu Dhabi and the wider GCC
Inflammation 48 (3), 10631077